M Zając

404 total citations
34 papers, 270 citations indexed

About

M Zając is a scholar working on Oncology, Organic Chemistry and Pharmacology. According to data from OpenAlex, M Zając has authored 34 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in M Zając's work include Analytical Methods in Pharmaceuticals (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Analytical Chemistry and Chromatography (4 papers). M Zając is often cited by papers focused on Analytical Methods in Pharmaceuticals (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers) and Analytical Chemistry and Chromatography (4 papers). M Zając collaborates with scholars based in Poland, United Kingdom and Germany. M Zając's co-authors include Anna Jelińska, Andrzej Bożek, Judyta Cielecka‐Piontek, Marlon C. Rebelatto, Jill Walker, M. Ratcliffe, Hytham Al‐Masri, Paul Scorer, Marietta Scott and Craig Barker and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

M Zając

34 papers receiving 257 citations

Peers

M Zając
Comparison fields: 5 of 87
  • Oncology 82
  • Molecular Biology 47
  • Pharmacology 41
  • Analytical Chemistry 39
  • Surgery 31
Replace Quanyun A. Xu with:
Quanyun A. Xu United States
Yoon‐Jee Chae South Korea
Jiang Ji China
Carol Astbury United Kingdom
Mary F. Kanz United States
Zuojun Li China
Miriam Sharpe
Vinod S. Chungi United States
E. E. M. Brouwers Netherlands
Rajendra Singh United States
Quanyun A. Xu United States View profile →
Citations per field, relative to M Zając
M Zając · 1×
Citations per year, relative to M Zając
M Zając · 1×

Countries citing papers authored by M Zając

Since Specialization
Citations

This map shows the geographic impact of M Zając's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Zając with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Zając more than expected).

Fields of papers citing papers by M Zając

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Zając. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Zając. The network helps show where M Zając may publish in the future.

Co-authorship network of co-authors of M Zając

This figure shows the co-authorship network connecting the top 25 collaborators of M Zając. A scholar is included among the top collaborators of M Zając based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Zając. M Zając is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 5
3 1
4 16
5 38
6 3
7 7
8 6
9
Development of validation of RP-HPLC method for determination of novel derivatives of daunorubicin
5
10 16
11
Development and validation of UV spectrophotometric and RP-HPLC methods for determination of ertapenem during stability studies
17
12
Stability of cetirizine dihydrochloride in solid state.
7
13
Stability of cefodizime disodium in solid state.
1
14
Determination of cetirizine dichloride in tablets by HPLC method.
13
15
Spectrophotometric (UV) and chromatographic (HPLC) methods for determination of loratadine hydrochloride in pharmaceutical preparations. Validation of the methods
1
16
Simultaneous spectrophotometric determination of acetylsalicylic acid, paracetamol and caffeine in pharmaceutical preparations
9
17
Kinetics of hydrolysis of ceftazidime in aqueous solutions.
1
18
Kinetics of drug decomposition. Part 67. Kinetics of degradation of dicloxacillin in aqueous solution.
1
19
Kinetics of drug decomposition. Part 61. Kinetics of various ampicillin forms degradation in solid phase.
2
20
Kinetics of drug decomposition. Part 37. Kinetics of autoxidation of narcotine in aqueous solutions.
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026